Ally Bridge Group (NY) LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$96.0M

Holdings

16

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (16 positions)

#StockSharesValue% PortfolioType
1
REPLREPLIMUNE GROUP INC
1,200,000$11.7M12.15%Call
2
EWTXEDGEWISE THERAPEUTICS INC
445,000$11.0M11.50%Put
3
ABVXABIVAX SA
70,000$9.4M9.83%
4
SLNOSOLENO THERAPEUTICS INC
168,029$7.8M8.10%
5
CMPSCOMPASS PATHWAYS PLC
1,100,000$7.6M7.91%Call
6
ATAIATAI BECKLEY NV
1,713,105$7.0M7.30%
7
IVAINVENTIVA SA
1,500,000$7.0M7.27%
8
NERVMINERVA NEUROSCIENCES INC
1,655,500$6.7M6.93%
9
PRAXPRAXIS PRECISION MEDICINES I
19,882$5.9M6.10%
10
TSHATAYSHA GENE THERAPIES INC
957,132$5.3M5.48%Call
11
QUREUNIQURE NV
200,000$4.8M4.99%Call
12
EPRXEUPRAXIA PHARMACEUTICALS INC
397,895$3.0M3.13%
13
OVIDOVID THERAPEUTICS INC
1,785,000$2.9M3.03%
14
SLDBSOLID BIOSCIENCES INC
413,625$2.3M2.43%
15
WHWKWHITEHAWK THERAPEUTICS INC
817,939$2.0M2.06%
16
PMNPROMIS NEUROSCIENCES INC
249,339$1.7M1.77%